Harrow HROW
NASDAQ HROW
$37.56 -0.29 (-0.77%)
As of: Sep 9, 2026 · 2:33 PM EDT

Harrow (HROW) Consolidated Net Income (2010 - 2026)

Harrow (HROW) posted Consolidated Net Income of -$17.3 million for Q2 2026, up 37.43% on a QoQ basis from -$27.6 million in Q1 2026, and down 445.75% year-over-year from $5.0 million in Q2 2025.

Analysis

Harrow (HROW) Consolidated Net Income (2010 - 2026) Analysis & Trends

Harrow has reported Consolidated Net Income for 17 years, with the latest figure at -$17.3 million in Q2 2026.

  • On a quarterly basis, Consolidated Net Income fell 445.75% year-over-year to -$17.3 million in Q2 2026; TTM through Jun 2026 was -$33.5 million, a 227.09% decrease from a year earlier, with the FY2025 full-year figure at -$5.1 million, up 70.6% from the prior year.
  • Consolidated Net Income was -$17.3 million for Q2 2026 at Harrow, up from -$27.6 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $10.4 million in Q4 2025, with the low at -$27.6 million in Q1 2026.
  • Average Consolidated Net Income over 5 years is -$5.7 million, with a median of -$5.3 million recorded in 2022.
  • The sharpest annual moves came in 2022 and 2025: Consolidated Net Income tumbled 1223.5% in 2022, then jumped 177.17% in 2025.
  • Over 5 years, Consolidated Net Income stood at $1.1 million in 2022, then sank by 967.11% to -$9.1 million in 2023, then soared by 174.08% to $6.8 million in 2024, then soared by 53.42% to $10.4 million in 2025, then plunged by 266.11% to -$17.3 million in 2026.
  • The last three Consolidated Net Income figures came in at -$17.3 million (Q2 2026), -$27.6 million (Q1 2026), and $10.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Johnson & Johnson 645.95 Bn 625.20 Bn 17.26 Bn 5.53 Bn
2 AbbVie 441.39 Bn 434.82 Bn 12.70 Bn 3.62 Bn
3 Merck 366.72 Bn 359.58 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 266.68 Bn 258.99 Bn 11.24 Bn 5.28 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn -238.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 2.16 Bn
7 Revolution Medicines 44.08 Bn 44.08 Bn - -644.37 Mn
8 Incyte 25.50 Bn 20.96 Bn 1.57 Bn 585.61 Mn
9 United Therapeutics 21.54 Bn 18.88 Bn 683.80 Mn 333.00 Mn
10 Harrow 1.40 Bn 1.32 Bn 50.36 Mn -17.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.27 Mn
Mar 31, 2026 -27.60 Mn
Dec 31, 2025 10.40 Mn
Sep 30, 2025 1.02 Mn
Jun 30, 2025 5.00 Mn
Mar 31, 2025 -17.78 Mn
Dec 31, 2024 6.78 Mn
Sep 30, 2024 -4.22 Mn
Jun 30, 2024 -6.47 Mn
Mar 31, 2024 -13.57 Mn
Dec 31, 2023 -9.15 Mn
Sep 30, 2023 -4.39 Mn
Jun 30, 2023 -4.23 Mn
Mar 31, 2023 -6.64 Mn
Dec 31, 2022 1.06 Mn
Sep 30, 2022 -6.46 Mn
Jun 30, 2022 -6.24 Mn
Mar 31, 2022 -2.44 Mn
Dec 31, 2021 -7.29 Mn
Sep 30, 2021 -8.33 Mn